PubRank

J Vestbo

Author PubWeight™ 116.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999 4.74
2 A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998 4.52
3 Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002 4.01
4 Developing COPD: a 25 year follow up study of the general population. Thorax 2006 3.72
5 Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998 3.45
6 Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited. Eur Respir J 2008 3.36
7 Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997 3.29
8 Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002 3.22
9 Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 2005 2.69
10 Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 2001 2.43
11 Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976-1998: a pooled cohort study. J Epidemiol Community Health 2003 2.13
12 Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009 2.11
13 COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J 2008 2.06
14 Recommendations for epidemiological studies on COPD. Eur Respir J 2011 1.84
15 Life expectancy in Danish women and men related to smoking habits: smoking may affect women more. J Epidemiol Community Health 1998 1.80
16 Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001 1.78
17 The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006 1.66
18 Risk of malignant neoplasms in patients with pulmonary sarcoidosis. Thorax 1997 1.62
19 Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 2002 1.60
20 Socioeconomic status and chronic obstructive pulmonary disease. Thorax 1999 1.60
21 Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax 2002 1.59
22 Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Eur Respir J 1999 1.56
23 Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J 1995 1.52
24 Mortality in women and men in relation to smoking. Int J Epidemiol 1998 1.52
25 Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J 2011 1.47
26 Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax 2010 1.46
27 Potential misclassification of causes of death from COPD. Eur Respir J 2006 1.42
28 Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Thorax 2008 1.34
29 Social position and mortality from respiratory diseases in males and females. Eur Respir J 2003 1.26
30 Measuring bronchodilation in COPD clinical trials. Br J Clin Pharmacol 2005 1.24
31 Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J 2010 1.23
32 Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med 2008 1.17
33 Gender and smoking-related risk of lung cancer. The Copenhagen Center for Prospective Population Studies. Epidemiology 1998 1.15
34 Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet 1996 1.14
35 Predictors of smoking reduction and cessation in a cohort of danish moderate and heavy smokers. Prev Med 2001 1.12
36 Effect of gender on hospital admissions for asthma and prevalence of self-reported asthma: a prospective study based on a sample of the general population. Copenhagen City Heart Study Group. Thorax 1997 1.11
37 Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease. Eur Respir J 2005 1.10
38 Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 2006 1.10
39 The International Journal of Tuberculosis and Lung Disease--a home for respiratory epidemiology. Int J Tuberc Lung Dis 1998 1.08
40 Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001 1.06
41 Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. Eur Respir J 1995 1.05
42 Increased T-regulatory cells within lymphocyte follicles in moderate COPD. Eur Respir J 2009 1.05
43 Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J 1993 1.04
44 Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1995 1.04
45 Exogenous female sex steroid hormones and risk of asthma and asthma-like symptoms: a cross sectional study of the general population. Thorax 2001 1.00
46 Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly? Am J Hypertens 1997 0.98
47 Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals. Clin Chem 2001 0.97
48 Increase in prevalence and severity of asthma in young adults in Copenhagen. Thorax 2000 0.97
49 Bronchodilator reversibility in COPD: the roguish but harmless little brother of airway hyperresponsiveness? Eur Respir J 2005 0.97
50 Candidate genes for COPD in two large data sets. Eur Respir J 2010 0.96
51 Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective. Eur Respir J Suppl 2003 0.94
52 Familial predisposition and susceptibility to the effect of other risk factors for myocardial infarction. J Epidemiol Community Health 1999 0.94
53 A comparison of mortality rates in three prospective studies from Copenhagen with mortality rates in the central part of the city, and the entire country. Copenhagen Center for Prospective Population Studies. Eur J Epidemiol 1998 0.93
54 Development, dimensions, reliability and validity of the novel Manchester COPD fatigue scale. Thorax 2009 0.91
55 Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an unexploited source of cardiovascular prevention: a prospective population-based study. J Hum Hypertens 1995 0.91
56 Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. Eur Respir J 2009 0.91
57 The association between aortic augmentation index and cardiovascular risk factors in a large unselected population. J Hum Hypertens 2011 0.89
58 Does cytomegalovirus predict a poor prognosis in Pneumocystis carinii pneumonia treated with corticosteroids? A note for caution. Chest 1995 0.88
59 Changes in smoking habits and risk of asthma: a longitudinal population based study. Eur Respir J 2001 0.85
60 Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004. Thorax 2005 0.83
61 Methods for therapeutic trials in COPD: lessons from the TORCH trial. Eur Respir J 2009 0.83
62 Highly significant linkage to chromosome 3q13.31 for rhinitis and related allergic diseases. J Med Genet 2006 0.83
63 Clinical characteristics and airway inflammation profile of COPD persistent sputum producers. Respir Med 2014 0.82
64 Significant linkage to chromosome 12q24.32-q24.33 and identification of SFRS8 as a possible asthma susceptibility gene. Thorax 2006 0.81
65 Interleukin-8 and leukotriene B4 in bronchoalveolar lavage fluid from HIV-infected patients with bacterial pneumonia. Respir Med 1997 0.81
66 CD8 chemokine receptors in chronic obstructive pulmonary disease. Clin Exp Immunol 2008 0.80
67 Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine. Respir Med 1999 0.80
68 Use of different exhaled nitric oxide multiple flow rate models in COPD. Eur Respir J 2007 0.80
69 Association of PTGDR gene polymorphisms with asthma in two Caucasian populations. Genes Immun 2007 0.80
70 Cardiovascular risk factor profile in subjects with familial predisposition to myocardial infarction in Denmark. J Epidemiol Community Health 1997 0.79
71 The pathophysiological role of mucus production in inflammatory airway diseases. Respir Med 1995 0.79
72 Penicillin as empirical therapy for patients hospitalised with community acquired pneumonia at a Danish hospital. Dan Med Bull 2001 0.78
73 Value of Tru-cut lung biopsy in focal and diffuse lung disease. Thorax 1988 0.78
74 COPD in the ECRHS. Thorax 2004 0.78
75 Outcomes in elderly Danish citizens admitted with community-acquired pneumonia. Regional differencties, in a public healthcare system. Respir Med 2012 0.78
76 Lung function decline in COPD trials. Eur Respir J 2009 0.77
77 GOLD and the fixed ratio. Eur Respir J 2011 0.77
78 Alveolar damage in AIDS-related Pneumocystis carinii pneumonia. Chest 1997 0.77
79 Bronchodilator and corticosteroid reversibility in ambulatory patients with airways obstruction. Dan Med Bull 1991 0.77
80 [Chronic expectoration and risk of death in chronic obstructive lung disease]. Ugeskr Laeger 1996 0.76
81 Is low intensity vibration harmful to the digits? Br J Ind Med 1985 0.75
82 Is lung function really a good parameter in evaluating the long-term effects of inhaled corticosteroids in COPD? Eur Respir J 2000 0.75
83 Another piece of the inhaled corticosteroids-in-COPD puzzle. Am J Respir Crit Care Med 2001 0.75
84 Statistical analysis of COPD exacerbations. Eur Respir J 2008 0.75
85 Counting, analysing and reporting exacerbations of COPD in randomised controlled trials. Thorax 2008 0.75
86 Inhaled steroids and mortality in COPD: bias from unaccounted immortal time. Eur Respir J 2004 0.75
87 [Diagnosis of pneumonia in artificially ventilated patients]. Ugeskr Laeger 1996 0.75
88 A sensitivity analysis of secular trends in risk factors and mortality based on cohort studies. Epidemiology 1999 0.75
89 [Prolonged exposure to lead as the cause of an organic psychosyndrome]. Ugeskr Laeger 1986 0.75
90 [Fluticasone propionate--a new inhalation steroid for the treatment of bronchial asthma]. Ugeskr Laeger 1996 0.75
91 The prognosis of extrapulmonary sarcoidosis. Sarcoidosis 1994 0.75
92 Has risk associated with smoking increased? Results from the Copenhagen Center for Prospective Population Studies. Int J Epidemiol 1997 0.75
93 [Sarcoidosis. Dependence of life expectancy on lung function, respiratory symptoms, roentgenologic stage and age at diagnosis and significance of extrapulmonary manifestations]. Versicherungsmedizin 1995 0.75
94 [Global strategy when it comes to chronic obstructive lung disease]. Ugeskr Laeger 2001 0.75
95 [Risk factors of death and hospitalization due to pneumonia. Results from the Osterbro study]. Ugeskr Laeger 1997 0.75
96 Scintigraphic demonstration of the thoracic duct following oral ingestion of 123I-heptadecanoic acid. Gastrointest Radiol 1989 0.75
97 CMV pneumonia and response to ganciclovir treatment in an AIDS patient. Respir Med 1991 0.75
98 [The time required for rewarming of fingers after provocation with cold. Comparison between crane drivers exposed to vibration and a control group]. Ugeskr Laeger 1983 0.75
99 [The course of pulmonary function in adults with asthma. The Osterbro study]. Ugeskr Laeger 2000 0.75
100 [Vibration-induced white fingers in the automobile industry. A questionnaire study]. Ugeskr Laeger 1985 0.75
101 Small-airways dysfunction in never smoking asbestos exposed Danish plumbers. Int Arch Occup Environ Health 1990 0.75
102 [Are obesity and overweight risk factors of asthma?]. Ugeskr Laeger 2001 0.75
103 [Prevalence of asthma among young adults in Copenhagen]. Ugeskr Laeger 2001 0.75
104 [Mortality in adults with asthma. Results from the Osterbro study]. Ugeskr Laeger 1997 0.75
105 [Glucocorticoids treatment of exacerbation of chronic obstructive lung diseases]. Ugeskr Laeger 2000 0.75
106 [Isolated systolic hypertension: a significant risk factor of cerebral apoplexy and acute myocardial infarction. A prospective population based study]. Ugeskr Laeger 1996 0.75
107 [Prognostic value of interleukin-8 in AIDS-related Pneumocystis carinii pneumonia]. Ugeskr Laeger 1996 0.75
108 [Humidifier fever--a differential diagnostic problem]. Ugeskr Laeger 1986 0.75
109 Rapid detection of cytomegalovirus in bronchoalveolar lavage fluid and serum samples by polymerase chain reaction: correlation of virus isolation and clinical outcome for patients with human immunodeficiency virus infection. Clin Infect Dis 1997 0.75
110 Evidence for an asthma risk locus on chromosome Xp: a replication linkage study. Allergy 2008 0.75
111 [Pneumocystis carinii pneumonia in HIV-infected patients examined by bronchoscopy during the period 1989-1991]. Ugeskr Laeger 1994 0.75
112 Electrocardiographic changes in patients with intrathoracic sarcoidosis: influence on prognosis. Sarcoidosis 1995 0.75
113 [Asthma and chronic obstructive lung disease. Prevention and treatment]. Ugeskr Laeger 2000 0.75
114 [Smoking and life expectancy among Danish men and women]. Ugeskr Laeger 1999 0.75